The major merozoite surface protein as a malaria vaccine target
Authors:
- W.R. BallouWBW.R. Ballou
- L.H. MillerLML.H. Miller
- 1 August 1993
- journal article
- research article
- Published by Elsevier in Parasitology Today
- Vol. 9 (8) , 300-302
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Analysis of sequence diversity in the Plasmodium falciparum merozoite surface protein-1 (MSP-1)Molecular and Biochemical Parasitology, 1993
- Vaccination with SPf66, a chemically synthesised vaccine, against Plasmodium falciparum malaria in ColombiaThe Lancet, 1993
- Evidence for a switching mechanism in the invasion of erythrocytes by Plasmodium falciparum.Journal of Clinical Investigation, 1990
- A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion-inhibiting antibodies.Journal of Experimental Medicine, 1990
- Immunization against Plasmodium falciparum with recombinant polypeptides produced in Escherichia coliParasite Immunology, 1988
- Epitopes Recognized by Human T Cells Map Within the Conserved Part of the GP190 of P. FalciparumScience, 1988
- Allelic dimorphism in a surface antigen gene of the malaria parasite Plasmodium falciparumJournal of Molecular Biology, 1987
- Major surface antigen gene of a human malaria parasite cloned and expressed in bacteriaNature, 1984
- Antimalarial immunity in Saimiri monkeys. Immunization with surface components of asexual blood stages.Journal of Experimental Medicine, 1984
- Immunization against blood-stage rodent malaria using purified parasite antigensNature, 1981